Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
Roxatidine acetate hydrochloride
Cat. No.:
OB0225LY-0121
Appearance:
Solid
Purity:
≥99%
Identity:
Confirmed by NMR and LC-MS.
Size:
Product Overview
Description:
Roxatidine acetate hydrochloride is an H2 receptor antagonist used to reduce gastric acid secretion.
Synonym:
HOE 760; Roxatidine acetate HCl; 93793-83-0; 2-Acetoxy-N-[3-[3-(1-piperidinomethylphenoxy]propyl]acetamide hydrochloride; Pifatidine hydrochloride; 2-oxo-2-((3-(3-(Piperidin-1-ylmethyl)phenoxy)propyl)amino)ethyl acetate hydrochloride; Acetamide, 2-(acetyloxy)-N-(3-(3-(1-piperidinylmethyl)phenoxy)propyl)-, monohydrochloride; Acetamide, 2-hydroxy-N-(3-(m-(1-piperidinylmethyl)phenoxy)propyl)-, acetate, hydrochloride; N-(3-(3-(N(1)-Piperidinylmethyl)phenoxy)propyl)acetoxyacetamide
CAS No.:
93793-83-0
Compound CID:
56704
Formula:
C19H29ClN2O4
Formula Weight:
384.9
Specification
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
Roxatidine acetate hydrochloride can be used to inhibit gastric acid secretion and ulcer formation.
Library Information
Targets:
Histamine receptor family
Receptors:
H2 receptor
Pathways:
GPCR/G protein; Neuronal signaling; Immunology/Inflammation
Plate Number:
AOCL-2
Plate Location:
e4
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10 mM DMSO
DMSO Max Solubility:
50 mg/mL; 129.90 mM
Water Max Solubility:
50 mg/mL; 129.90 mM
